Author: Gianpiero Pescarmona Date: 15/08/2019
The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells, 2018
Inhibiting the system xC/glutathione axis selectively targets cancers with mutant-p53 accumulation, 2016
PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms, 2015
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies, 2017
APR-246+GSH
Cystine/glutamate transporter ?
